ACADIA HEALTHCARE CO INC (ACHC) Forecast, Price Target & Analyst Ratings
NASDAQ:ACHC • US00404A1097
25.14 USD
+0.43 (+1.74%)
At close: Mar 10, 2026
24.64 USD
-0.5 (-1.99%)
After Hours: 3/10/2026, 8:04:48 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACADIA HEALTHCARE CO INC (ACHC).
Forecast Snapshot
Consensus Price Target
$19.53
-22.33% Downside
Next Earnings Forecast
Release DateMay 11, 2026
PeriodQ1 / 2026
EPS Estimate$0.26
Revenue Estimate839.38M
ChartMill Buy Consensus
74.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$19.53
Upside
-22.33%
From current price of $25.14 to mean target of $19.53, Based on 20 analyst forecasts
Low
$13.13
Median
$18.87
High
$26.25
Price Target Revisions
1 Month
-1.83%
3 Months
-11.26%
Price Target Summary
20 Wall Street analysts provided a forecast for the next 12 months for ACHC. The average price target is 19.53 USD. This implies a price decrease of -22.33% is expected in the next year compared to the current price of 25.14.
The average price target has been revised downward by 11.26% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
74.00%
ACHC was analyzed by 20 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about ACHC.
In the previous month the buy percentage consensus was at a similar level.
ACHC was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-03 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-26 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2026-02-26 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-26 | UBS | Maintains | Buy -> Buy |
| 2026-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-23 | Guggenheim | Maintains | Buy -> Buy |
| 2026-01-22 | Jefferies | Downgrade | Buy -> Hold |
| 2026-01-16 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-18 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-12-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-03 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-12-03 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-12-03 | UBS | Maintains | Buy -> Buy |
| 2025-12-03 | Deutsche Bank | Maintains | Buy -> Buy |
| 2025-12-03 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-12-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-03 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-11-18 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-11-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-07 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-11-07 | UBS | Maintains | Buy -> Buy |
| 2025-11-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-08 | Keybanc | Maintains | Overweight -> Overweight |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 11, 2026
PeriodQ1 / 2026
EPS Estimate$0.26
Revenue Estimate839.38M
Revenue Q2Q8.94%
EPS Q2Q-34.98%
Number of Analysts15
Next Earnings Revisions
Revenue (1 Month)
1.60%
Revenue (3 Months)
1.19%
EPS (1 Month)
-21.95%
EPS (3 Months)
-28.77%
Next Earnings Summary
ACHC is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is 0.26 USD and the consensus revenue estimate is 839.38M USD.
The next earnings revenue estimate has been revised upward by 1.19% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.929B 12.19% | 3.154B 7.69% | 3.313B 5.04% | 3.486B 5.23% | 3.694B 5.97% | 3.9B 5.58% | 4.28B 9.74% | N/A | N/A | |
| EBITDA YoY % growth | 638.945M 13.29% | 671.871M 5.15% | 577.214M -14.09% | 608.56M 5.43% | 649.59M 6.74% | 683.86M 5.28% | 981.24M 43.49% | 1.039B 5.89% | 1.039B | |
| EBIT YoY % growth | 506.596M 13.54% | 522.276M 3.10% | 387.965M -25.72% | 406.66M 4.82% | 424.99M 4.51% | N/A | N/A | N/A | N/A | |
| Operating Margin | 17.30% | 16.56% | 11.71% | 11.67% | 11.50% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 3.43 -10.91% | 3.30 -3.79% | 2.02 -38.79% | 1.50 -25.62% | 1.73 15.38% | 1.92 10.67% | 1.87 -2.71% | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.26 -34.98% | 0.50 -39.67% | 0.59 -17.86% | 0.41 489.82% | 0.43 66.20% | 0.83 65.44% | 0.71 20.18% | 0.55 32.32% |
| Revenue Q2Q % growth | 839.38M 8.94% | 883.57M 1.65% | 899.25M 5.60% | 855.97M 4.20% | 888.82M 5.89% | 970.27M 9.81% | 947.95M 5.42% | 915.66M 6.97% |
| EBITDA Q2Q % growth | 136.6M 8.82% | 168.99M -29.09% | 174.36M -33.71% | 151.54M -36.03% | 152.29M 11.49% | 208.77M 23.54% | 192.34M 10.31% | 171.78M 13.36% |
| EBIT Q2Q % growth | 77.474M -1.30% | 109.03M -23.38% | 119.74M 0.18% | 99.784M 109.44% | 98.573M 27.23% | 146.52M 34.39% | 134.4M 12.24% | 117.4M 17.65% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-1.70%
EPS Next 5 Year
-1.96%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
5.12%
Revenue Next 5 Year
6.26%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
18.00%
EBIT Next 5 Year
20.08%
ACADIA HEALTHCARE CO INC / ACHC Forecast FAQ
Can you provide the average price target for ACADIA HEALTHCARE CO INC stock?
20 analysts have analysed ACHC and the average price target is 19.53 USD. This implies a price decrease of -22.33% is expected in the next year compared to the current price of 25.14.
What is the next earnings date for ACHC stock?
ACADIA HEALTHCARE CO INC (ACHC) will report earnings on 2026-05-11, after the market close.
Can you provide the consensus estimates for ACADIA HEALTHCARE CO INC next earnings?
The consensus EPS estimate for the next earnings of ACADIA HEALTHCARE CO INC (ACHC) is 0.26 USD and the consensus revenue estimate is 839.38M USD.
How many analysts have analysed ACADIA HEALTHCARE CO INC (ACHC)?
The number of analysts covering ACADIA HEALTHCARE CO INC (ACHC) is 20.